Myhre Syndrome
Description
Myhre syndrome is characterised by striking muscular build, short stature, reduced joint mobility, brachydactyly, mixed hearing loss and mental retardation of variable severity. Facial dysmorphism with short palpebral fissures, short philtrum, thin lips, maxillary hypoplasia and prognathism is present. Thick skin has been observed in six patients.
Clinical Features
Top most frequent phenotypes and symptoms related to Myhre Syndrome
- Intellectual disability
 - Seizures
 - Global developmental delay
 - Short stature
 - Hearing impairment
 - Microcephaly
 - Ataxia
 - Growth delay
 - Hypertelorism
 - Strabismus
 
And another 138 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Myhre Syndrome Is also known as laryngotracheal stenosis, arthropathy, prognathism, and short stature, laps syndrome, growth-mental deficiency syndrome of myhre, facial dysmorphism-intellectual disability-short stature-hearing loss syndrome.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Myhre Syndrome Recommended genes panels
| Panel Name, Specifity and genes Tested/covered | 
|---|
 	Hereditary Pancreatic Cancer Panel.
By Baylor Miraca Genetics Laboratories (United States). 
BMPR1A, BRCA1, BRCA2, STK11, EPCAM, TP53, CDK4, CDKN2A, PALB2, APC, SMAD4, MLH1, MSH2, MSH6, ATM, PMS2, RAD50
 
Specificity
 
6 % 
Genes
 
100 %  | 
 	High Risk Hereditary Colorectal Cancer Panel.
By Baylor Miraca Genetics Laboratories (United States). 
BMPR1A, STK11, EPCAM, TP53, APC, SMAD4, MLH1, MSH2, MSH6, MUTYH, PMS2, PTEN
 
Specificity
 
9 % 
Genes
 
100 %  | 
 	Comprehensive Hereditary Cancer Panel.
By Baylor Miraca Genetics Laboratories (United States). 
RUNX1, SDHA, SDHB, SDHC, SDHD, BMPR1A, BRCA1, BRCA2, STK11, EPCAM, TP53, VHL, WT1, CBL, SUFU, CDC73, CDH1, CDK4, CDKN1C, CDKN2A	, (...)
 
View the complete list with 39 more genes 
Specificity
 
2 % 
Genes
 
100 %  | 
 	Hereditary Colorectal/Gastrointestinal Cancer Panel.
By Baylor Miraca Genetics Laboratories (United States). 
BMPR1A, BRCA1, BRCA2, STK11, EPCAM, TP53, CDH1, CDK4, CDKN2A, PALB2, ENG, APC, SMAD4, MLH1, MSH2, MSH6, MUTYH, ATM, PMS1, PMS2	, (...)
 
View the complete list with 1 more genes 
Specificity
 
5 % 
Genes
 
100 %  | 
 	Comprehensive Pulmonary Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States). 
RPGR, SCNN1A, SCNN1B, SCNN1G, BMPR1B, BMPR2, SFTPA1, SFTPA2, SFTPB, SFTPC, SFTPD, SLC7A7, SPAG1, STAT3, TERC, TERT, TINF2, NKX2-1, TSC1, TSC2	, (...)
 
View the complete list with 73 more genes 
Specificity
 
2 % 
Genes
 
100 %  | 
 	Arterial Hypertension Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States). 
BMPR1B, BMPR2, CAV1, ACVRL1, ABCA3, ENG, GDF2, KCNA5, KCNK3, SMAD4, SMAD9
 
Specificity
 
10 % 
Genes
 
100 %  | 
 	NGS Vascular Disorders Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States). 
SOX18, TEK, VEGFC, GLMN, KRIT1, STAMBP, GJC2, ACVRL1, CCM2, CCBE1, ENG, FLT4, FOXC2, GATA2, GDF2, KIF11, SMAD4, PDCD10, PTEN, PTPN14	, (...)
 
View the complete list with 1 more genes 
Specificity
 
5 % 
Genes
 
100 %  | 
 	SMAD4 Gene Characterization.
By Molecular Pathology Laboratory University of Pennsylvania Health System (United States). 
SMAD4
 
Specificity
 
100 % 
Genes
 
100 %  | 
You can get up to 263 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM ORPHANET MESH Rare Disease Search EngineIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3 LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2 METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC
	Hereditary Pancreatic Cancer Panel.